摘要 |
<p>The invention provides novel in vitro diagnostic methods for identifying subjects or patients who may have an increased likelihood of responding to DPP-IV inhibitor therapy. The invention also provides novel polynucleotides associated with increased responsiveness of a patient to DPP-IV inhibition. Polynucleotide fragments which comprise at least one polymorphic locus, are also provided. Allele-specific primers and probes which hybridize to these polymorphic regions, and/or which comprise at least one polymorphic locus are also provided. The polynucleotides, primers, and probes of the invention are useful in phenotype correlations, medicine, and genetic analysis.</p> |
申请人 |
BRISTOL-MYERS SQUIBB COMPANY;ASTRAZENECA UK LIMITED;EMISON, EILEEN;DELMONTE, TERRYE, AIGELDINGER;RANADE, KOUSTUBH;RODRIGUEZ, LISA, RENEE;SIMONSEN, KATY, LYNN MOORE |
发明人 |
EMISON, EILEEN;DELMONTE, TERRYE, AIGELDINGER;RANADE, KOUSTUBH;RODRIGUEZ, LISA, RENEE;SIMONSEN, KATY, LYNN MOORE |